Avextra 10/10 Cannabis Extract in Sesame Linseed Oil Shows Promise
A Phase II randomized controlled trial evaluated Avextra 10/10 cannabis extract clinical trial for treating neurodegenerative diseases using a rigorous double-blind design. The study assessed both therapeutic benefits and safety profiles of this…
Medical Cannabis for Autoimmune Pain Management According to Dr. Caplan
Patients with autoimmune conditions are increasingly turning to medical cannabis for autoimmune pain when traditional therapies prove insufficient. Dr. Caplan's clinical experience shows cannabis can provide meaningful adjunctive relief, though evidence…
Limited Evidence for Topical CBD Pain Relief According to Recent Study
Recent research challenges widespread claims about topical CBD for pain relief, finding insufficient evidence to support its effectiveness for musculoskeletal soreness. While topical CBD for pain has gained popularity among consumers, clinical trials…
The United States just offically recliassified cannabis. The federal reclassification of medical …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustrySafetyMental HealthPainAnxiety Why This Matters The reclassification of cannabis from Schedule I to…
Only 1 in 5 Older Cannabis Users Tell Doctors | Trending – Labroots
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AgingResearchSafetyMental HealthPolicyPainAnxiety Why This Matters Clinicians may be unaware of cannabis use in 80%…
Can Cannabis Help Slow Alzheimer’s Disease? A Recent Study Says It Might – AOL
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. NeurologyResearchAgingCBDTHCMental HealthSafety Why This Matters I need the complete article summary to provide an…
Can Cannabis Help Slow Alzheimer’s Disease? A Recent Study Says It Might – Food & Wine
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchCBDNeurologyAgingSafetyMental HealthAnxiety Why This Matters Clinicians caring for Alzheimer’s patients…
Avicanna Announces Closing of Non-Brokered Private Placement | Markets Insider
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryCBDTHCSafetyPolicyPain Clinical Summary Avicanna has completed a non-brokered private placement to fund…
Opinion: Cannabis, medicine and the crisis of public trust – Anchorage Daily News
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyMental HealthPainAnxietyCBD Clinical Summary This opinion piece addresses the erosion of public…
Identification of cannabichromevarin as a potent stabilizer of the measles virus prefusion F protein
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyNeurologyMental HealthCBDHempIndustry Why This Matters This research identifying cannabichromevarin (CBCV)…